MicroRNAs in Acute Kidney Injury

Background: It is increasingly recognised that improved diagnosis, prognosis and treatment of acute kidney injury (AKI) requires an understanding of distinct underling cellular and molecular mechanisms (endotypes) that may distinguish overtly similar clinical AKI presentations. One important avenue of research is the post-transcriptional regulation of gene expression in response to kidney injury mediated by microRNAs. Summary: This mini-review summarises the use of microRNAs as diagnostic and prognostic biomarkers in AKI. The contribution of microRNAs to the pathophysiology of AKI will be highlighted along with the potential for therapeutic applications. Key Messages: While there is great potential for a better understanding of AKI, microRNAs form a complex regulatory network. Understanding the role and significance of microRNAs in the context of AKI and critical illness is a major endeavour in translational medicine, requiring the integration of clinical and experimental data.

[1]  John A. Kellum,et al.  Paradigms of acute kidney injury in the intensive care setting , 2018, Nature Reviews Nephrology.

[2]  N. Tatonetti,et al.  Unique Transcriptional Programs Identify Subtypes of AKI. , 2017, Journal of the American Society of Nephrology : JASN.

[3]  Henning Urlaub,et al.  A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. , 2017, Molecular cell.

[4]  Z. Dong,et al.  MicroRNA-375 Is Induced in Cisplatin Nephrotoxicity to Repress Hepatocyte Nuclear Factor 1-β* , 2017, The Journal of Biological Chemistry.

[5]  Yu-Sun Chang,et al.  MicroRNAs in acute kidney injury , 2016, Human Genomics.

[6]  T. Walther,et al.  Plasma microRNA-21 for the early prediction of acute kidney injury in patients undergoing major cardiac surgery. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  E. Izaurralde,et al.  Towards a molecular understanding of microRNA-mediated gene silencing , 2015, Nature Reviews Genetics.

[8]  B. Ponte,et al.  A Pilot Study Identifying a Set of microRNAs As Precise Diagnostic Biomarkers of Acute Kidney Injury , 2015, PloS one.

[9]  S. Waikar,et al.  Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. , 2013, Clinical chemistry.

[10]  Shengshou Hu,et al.  MicroRNA-21 and Risk of Severe Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery , 2013, PloS one.

[11]  Yen-Ta Huang,et al.  MicroRNA-494 reduces ATF3 expression and promotes AKI. , 2012, Journal of the American Society of Nephrology : JASN.

[12]  Ronald P. Brown,et al.  Expression, circulation, and excretion profile of microRNA-21, -155, and -18a following acute kidney injury. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  D. Fliser,et al.  Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[14]  Jessica A. Weber,et al.  The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.

[15]  Z. Dong,et al.  Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. , 2010, Journal of the American Society of Nephrology : JASN.